| 繁體中文 | English
首页 | 学术期刊 | 学位论文 | 学术会议 | 中外专利 | 中外标准 | 科技成果 | 新方志 | 法律法规 | 专题
浏览历史
首页 > NSTL期刊 > 其它
FOR THE PAST CENTURY, THE PATHOGENESIS OF AGE-related macular degeneration (AMD) has remained unclear. Treatments developed over the past two decades focus on late-stage disease, where our knowledge is most comprehensive. Understanding the first stages of AMD may allow us to develop interventions earlier in the disease and save vision.The etiology of AMD, I believe, is largely attributable to impairment of choroidal perfusion. Atherosclerosis increases scleral rigidity. Scleral rigidity, in turn, interferes with choroidal venous drainage of retinal lipoproteins; and, finally, the accumulation of these lipoproteins is responsible for the retinal damage seen in early AMD. Progression to the neovascular form results from angio-genic factors such as vascular endothelial growth factor (VEGF). Photoreceptor loss occurs in geographic atrophy and neovascular AMD secondary to apoptosis and necrosis.